Statement Of Changes In Equity [Abstract]

Xspray Pharma - Filing #679275

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transactions with owners, equity
8 573 SEK
308 673 SEK
317 246 SEK
SEK
- SEK
2 000 SEK
SEK
95 937 SEK
SEK
- SEK
93 937 SEK
Share issue related cost
- SEK
26 201 SEK
26 201 SEK
- SEK
- SEK
SEK
- SEK
4 876 SEK
SEK
- SEK
4 876 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.